Head-to-head · Value Score
yourEra vs Invigor Medical
Two GLP-1 deals, scored on the same six factors. yourEra lands a Value Score of 84, Invigor Medical a 82. Here's who gives you the honest lower price — and where each one bites back.
yourEra
#25 · Grade B+ · Good Value
Est. first month
$199/mo
Save ~85% vs brand-nameInvigor Medical
#49 · Grade B+ · Good Value
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
yourEra takes it on Value Score, 84 to 82 — an est. $199/mo first month, with no teaser step-up baked in. Invigor Medical isn't out of it: People who want GLP-1 pricing they can see up front alongside a wider wellness/hormone catalog.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | yourEra | Invigor Medical |
|---|---|---|
| Value Score | 84 (B+) | 82 (B+) |
| Est. first month | $199/mo | $199/mo |
| Save vs brand-name | ~85% | ~85% |
| Semaglutide | $199/mo | $199/mo |
| Tirzepatide | $299/mo | $339/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Not disclosed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
yourEra
A transparent, publicly priced GLP-1 program — both molecules at $199/$299 with no hidden quiz-wall — that's honest and mid-market rather than rock-bottom.
Why it's a deal
- Publishes prices openly on the site — $199 sema / $299 tirz — while many compounders hide pricing behind an intake quiz
- Both compounded semaglutide and tirzepatide, plus a broader menu (NAD+, microdosing, optional coaching/nutritionist/lab bundle)
- Markets a 50-state licensed-clinician network; no insurance required and HSA/FSA accepted
The fine print
- Mid-market pricing — $199/$299 sits above the cheapest compounders (~$99–$150), so it's not the value leader
- Compounded only and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound, and availability can tighten as brand shortages resolve
- Injectable only — no FDA-approved brand-name lane and no oral option
- Thin independent footprint; the 50-state and efficacy claims are self-reported
Invigor Medical
Mid-market flat pricing on both molecules from a long-running, broad-catalog operator.
Why it's a deal
- Both molecules priced up front
- Long-running operator with a broad catalog
- No known teaser-rate tier
The fine print
- Tirzepatide ($339) runs pricier than the best deals
- Does not publish an explicit states-served list
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores yourEra is ranked on the yourEra alternatives ranking, and the same list for the other side is on alternatives to Invigor Medical.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.